We are pleased to announce that materials analysis, particularly for the pharmaceutical industry continues to perform strongly. In order to fulfil the needs of the pharmaceutical industry, a range of approved quality procedures have been developed to meet the requirements of these clients and FDA/MHRA regulations with respect to current GMP. Two newly-designed laboratories are now in use with dedicated areas for the GC-MS and GC-FID facilities for cGMP leachables testing. The GC-MS equipment has the latest inert source detectors, and other capabilities include headspace GC-NPD testing for acrylonitrile monomer, and headspace GC-FID for detection of volatile organics.

For further information please contact Sue Stephens